Chennai: Indigenously researched and developed bioresorbable scaffold (BRS) MeRes100 has been launched in India.
Bioresorbable scaffolds are non-metallic, non-permanent mesh tubes, similar to stents, that dissolve over time after ensuring the previously blocked artery is opened via a routine angioplasty procedure.
This novel therapy option,which can meaningfully treat an identified subset of the patient population, is being launched in a phased, sequential manner to ensure adherence to best clinical practices and continued development of clinical research and long-term evidence.
Currently, MeRes100 by Meril Life Sciences is being launched in 16 cities across India, including Mumbai, Delhi, Gurgaon, Bangalore, Chennai, Pune, Hyderabad, Ahmedabad, Lucknow, Chandigarh, Mohali, Jaipur, Kochi, Eddakad, Nagpur and Bhubaneswar.